How to buy Acurx Pharmaceuticals IncCommon Stock stock

Acurx Pharmaceuticals, Inc. Common Stock is a business based in the US. Acurx Pharmaceuticals IncCommon Stock shares (ACXP) are listed on the NASDAQ and all prices are listed in US Dollars. Acurx Pharmaceuticals IncCommon Stock employs 2 staff and has a market cap (total outstanding shares value) of 0.00.

Acurx Pharmaceuticals IncCommon Stock stock price (NASDAQ: ACXP)

Use our graph to track the performance of ACXP stocks over time.

Acurx Pharmaceuticals IncCommon Stock shares at a glance

• Key figures

Information last updated 2021-07-28.

52-week range	$5.03 - $8.74
50-day moving average	$5.94
200-day moving average	$5.94
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Acurx Pharmaceuticals IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Acurx Pharmaceuticals IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Acurx Pharmaceuticals, Inc. Common Stock by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acurx Pharmaceuticals IncCommon Stock financials

Gross profit TTM	$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	$0.18
Market capitalisation	$51.6 million

TTM: trailing 12 months

Shorting Acurx Pharmaceuticals IncCommon Stock shares

There are currently 10,672 Acurx Pharmaceuticals IncCommon Stock shares held short by investors – that's known as Acurx Pharmaceuticals IncCommon Stock's "short interest". This figure is 30.2% up from 8,199 last month.

There are a few different ways that this level of interest in shorting Acurx Pharmaceuticals IncCommon Stock shares can be evaluated.

Acurx Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR)

Acurx Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR) is the quantity of Acurx Pharmaceuticals IncCommon Stock shares currently shorted divided by the average quantity of Acurx Pharmaceuticals IncCommon Stock shares traded daily (recently around 1.1 million). Acurx Pharmaceuticals IncCommon Stock's SIR currently stands at 0.01. In other words for every 100,000 Acurx Pharmaceuticals IncCommon Stock shares traded daily on the market, roughly 10 shares are currently held short.

To gain some more context, you can compare Acurx Pharmaceuticals IncCommon Stock's short interest ratio against those of similar companies.

• Pfizer (PFE.US): 3.09
• Novartis (NVS.US): 3.8
• Merck-and-CoInc (MRK.US): 1.85

However Acurx Pharmaceuticals IncCommon Stock's short interest can also be evaluated against the total number of Acurx Pharmaceuticals IncCommon Stock shares, or, against the total number of tradable Acurx Pharmaceuticals IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acurx Pharmaceuticals IncCommon Stock's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Acurx Pharmaceuticals IncCommon Stock shares in existence, roughly 0 shares are currently held short) or 0.001% of the tradable shares (for every 100,000 tradable Acurx Pharmaceuticals IncCommon Stock shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acurx Pharmaceuticals IncCommon Stock.

Find out more about how you can short Acurx Pharmaceuticals IncCommon Stock stock.

Acurx Pharmaceuticals IncCommon Stock share dividends

We're not expecting Acurx Pharmaceuticals IncCommon Stock to pay a dividend over the next 12 months.

You may also wish to consider:

• Pfizer (PFE.US) (3.55% forward annual dividend yield)
• Novartis (NVS.US) (3.72% forward annual dividend yield)
• Merck-and-CoInc (MRK.US) (3.17% forward annual dividend yield)

Acurx Pharmaceuticals IncCommon Stock overview

Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York. .

Frequently asked questions

What percentage of Acurx Pharmaceuticals IncCommon Stock is owned by insiders?
Currently 24.588% of Acurx Pharmaceuticals IncCommon Stock shares are held by insiders. How many people work for Acurx Pharmaceuticals IncCommon Stock?
Latest data suggests 2 work at Acurx Pharmaceuticals IncCommon Stock. When does the fiscal year end for Acurx Pharmaceuticals IncCommon Stock?
Acurx Pharmaceuticals IncCommon Stock's fiscal year ends in December. Where is Acurx Pharmaceuticals IncCommon Stock based?
Acurx Pharmaceuticals IncCommon Stock's address is: 259 Liberty Avenue, Staten Island, NY, United States, 10305